Detalhe da pesquisa
1.
Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort study.
AIDS Res Ther
; 20(1): 1, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597160
2.
Brief Report: Incidence and Management of Complex Kidney Situations Among On-Demand and Daily HIV Pre-Exposure Prophylaxis Users.
J Acquir Immune Defic Syndr
; 95(3): 255-259, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37977193
3.
Updated mortality and causes of death in 2020-2021 in people with HIV: a multicenter study in France.
AIDS
; 37(13): 2007-2013, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428209
4.
Brief Report: Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in France.
J Acquir Immune Defic Syndr
; 91(1): 85-90, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616997
5.
Mortality of People Living with HIV in Paris Area from 2011 to 2015.
AIDS Res Hum Retroviruses
; 36(5): 373-380, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31565958
6.
Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in France.
AIDS
; 32(15): 2161-2169, 2018 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30212403